Advertisement

Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 600x60px
Document › Details

Kinaxo Biotechnologies GmbH. (1/11/07). "Press Release: Kinaxo Announces Agreement with Johnson & Johnson". Martinsried.

Organisations Organisation Johnson & Johnson Pharmaceutical Research & Development LLC (J&JPRD)
  Today Janssen Research & Development LLC
  Group Johnson & Johnson (JnJ) (Group)
  Organisation 2 Kinaxo Biotechnologies GmbH
  Group Evotec (Group)
Products Product Cellular Target Profiling technology (Kinaxo)
  Product 2 mass spectrometry (MS)
Index term Index term JnJ–Kinaxo: KinaTor technology, 200701– target selectivity analyses for selected JnJ small molecule compounds
     


KINAXO Biotechnologies GmbH announced today that it has entered an agreement with Johnson & Johnson Pharmaceutical Research & Development (J&JPRD), a division of Janssen Pharmaceutica N.V., Beerse, Belgium. Under the agreement, KINAXO will use the KinaTorTM technology to perform target selectivity analyses for selected J&JPRD small molecule compounds.

The KinaTorTM technology uses immobilized small molecule inhibitors to detect their protein binding partners in biological samples. Small molecule-protein interactions are identified by a combination of sophisticated affinity-based separation procedures and sensitive mass spectrometry. The KinaTorTM provides tailor-made solutions for various problems in drug development, such as the identification of previously unknown disease-relevant targets as well as off-target related toxicities.

About KINAXO

KINAXO is a spin-off from the Max Planck Institute of Biochemistry in Martinsried, initiated by Prof. Dr. Axel Ullrich and Dr. Henrik Daub as well as Max Planck Innovation GmbH, the technology transfer center of the Max Planck Society. KINAXO offers a comprehensive chemical proteomics technology - known as KinaTorTM - to identify and characterize the biological interaction of small molecule inhibitors with their protein targets in the physiological context of a cell.


   
Record changed: 2016-03-19

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Johnson & Johnson (JnJ) (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px